FDA
approval
· 2022-12-27
FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Aurobindo Pharma Limited)
Summary
FDA approves the original application for solifenacin succinate (generic) by Aurobindo Pharma Limited as a treatment option for overactive bladder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)